[Recalled] ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC — There is a potential for separation of the ANGIOGUARD RX / XP delivery system a… | FDA 2023-03-24
Regulators flagged this product in an official safety action. Here is what the notice says and what it means for owners.
Recall details
| Product | ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC |
|---|---|
| Brand / manufacturer | Cordis US Corp |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-1489-2023 |
| Country of notice | United States |
| Risk level | Class I |
| Hazard type | recall |
| Notice date | 24 March 2023 |
| EAN / barcode | 20705032054789 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.
This Class I recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Stop using the product immediately and follow the authority's remedy (return, repair, or disposal).
Read the full official notice →
Related recalls from Cordis US Corp
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.